Environmental monitoring is the repeated measurement of physical, chemical and biological variables in order to study environmental changes, particularly those arising from human activities.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Eldredge finally found relief. He said things immediately got better about six months ago when he tried Spravato. “It’s so life-changing,” said Eldredge. Spravato is a ketamine-derived nasal ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients ... or more antidepressants.

Spravato is a form of esketamine that patients take as a self-administered ... Esketamine is available through the Risk Evaluation and Mitigation Strategy (REMS) program, which prevents and monitors ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Spravato is the brand name for esketamine, a chemical form of the anesthetic drug ketamine ... a Risk Evaluation and Mitigation Strategy (REMS). Meaning, you have to go to a specialty treatment ...

Titusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO (esketamine) CIII nasal spray, making this ...

It's called Spravato, made by Johnson and Johnson and it works faster than standard oral antidepressants. Spravato was first approved back in 2019, but at that time, patients had to use it with an ...

Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder (MDD) in adults who do not ...